Cocrystal Pharma Inc（COCP）價格預測COCPCocrystal Pharma Inc

Alphio's COCP stock price prediction model matches the current Cocrystal Pharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.13 (+0.40%). The 1-week path is $1.16 (+2.83%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Cocrystal Pharma Inc is currently not a strong buy due to its ongoing financial struggles and recent stock performance. The stock closed at $1.10, down 4.35% over the last five days, and has a negative forward P/E ratio of 0, indicating no expected earnings growth in the near term. While the recent FDA Fast Track designation for CDI-988 is a positive catalyst, the company reported a significant net loss of $3.16 million in Q2 2026, raising concerns about its financial stability. The RSI is at 45.67, suggesting the stock is neither overbought nor oversold, which supports a hold position rather than a buy. The main risk is the company's liquidity pressure, with unrestricted cash decreasing from $7.7 million to $4.7 million in just a few months, which could impact operations.

Cocrystal Pharma Inc (COCP) last closed at $1.13, losing -2.59%. These facts feed the 1-day and 1-week COCP price prediction above.